NIH Update Regarding Oversight of Foreign Subawards
NIH leadership discuss 2023 policy clarifications on oversight of foreign subawards requirements, offering background information and highlighting further clarifications made in response to public comment. Following presentations from NIH directors, NIH panelists delve further into questions and comments from the community during a moderated Q&A session.
00:00 Introduction
01:17 Dr. Lawrence Tabak, Acting Director, NIH
04:28 Response to OIG and GAO Audits, presented by Dr. Michael Lauer, Deputy Director for Extramural Research, NIH
26:05 Q&A